AgNovos Healthcare has generated strong interest with the Breakthrough Designation by the FDA and was mentioned in reputable press portals
The recently issued press release on the FDA's "Breakthrough Designation" for AgNovos' newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has generated a strong of interest in the industry and has been posted on several reputable press portals. Below you will find a few links: